Efficacy and Safety of Apremilast in Psoriasis
Clinical trial NCT06032858 · COMPLETED
Trial details
- NCT number
- NCT06032858
- Sponsor
- Ghurki Trust and Teaching Hospital
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-06
- Primary completion
- 2023-07-10
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.